腰部熏腰方联合物理因子治疗骨质增生腰痛临床观察
|
摘要
目的:探讨腰部熏腰方联合物理因子治疗骨质增生腰痛的临床效果。方法:选择骨质增生性腰痛的患者86名,按照随机数字的方法分为两个组,对照组和观察组,每个组43名患者,对照组患者采用物理因子治疗,观察组患者在对照组治疗方法基础上给予腰部熏蒸,对疼痛程度,血清分泌蛋白Dickkopf-1(DKK-1)和硬骨素水平,治疗效果,不良反应情况进行比较。结果:经过治疗后,对照组患者的疼痛评级指数(PRI),视觉模拟级评定(VAS),目前疼痛状况(PPI)评分,分别从(21.11±3.86)分,(8.13±1.35)分,(3.73±0.83)分降低为(13.51±3.15)分,(4.51±0.97)分,(1.57±0.48)分,观察组患者的PRI, VAS, PPI评分,分别从(20.86±4.01)分,(8.21±1.47)分,(3.86±0.79)分降低为(7.06±2.04)分,(2.36±0.87)分,(0.92±0.23)分,观察组患者的降低幅度大于对照组患者,数据差异均具有统计学意义(t=11.270,10.820,8.008,P<0.05)。观察组患者的治疗效果优于对照组患者,数据差异具有统计学意义(z=-3.253,P<0.05),在治疗过程中,两组患者的各项不良反应发生率的数据差异均不具有统计学意义(χ~2=0.345,1.012,0.000,P>0.05)。结论:使用腰部熏蒸联合物理因子治疗骨质增生腰痛的患者,可以缓解疼痛,提高治疗效果,安全性良好。
Objective:To explore the clinical effect of lumbar stagnation combined with physical factors in the treatment of bone hyperplasia and low back pain. Methods:86 patients with osteoproliferative low back pain were selected. According to the random number method, the patients were divided into two groups, the control group and the observation group, with 43 patients in each group. Patients in the control group were treated with physical factors, while those in the observation group were given lumbar fumigation on the basis of the treatment methods in the control group. Comparisons of pain severity, serum secretory protein Dickkopf-1(DKK-1) and osteocalcin levels, therapeutic effects and adverse reactions were carried out. Results:After treatment, the pain score index(PRI), visual analog scale(VAS), and current pain status(PPI) scores of the control group were 21.11±3.86, 8.13±1.35 and 3.73±0.83. The score was reduced to 13.51±3.15, 4.51±0.97 and 1.57±0.48. The PRI, VAS and PPI scores of the observation group were reduced from 20.86±4.01, 8.21±1.47 and 3.86±0.79 to 7.06±2.04, 2.36±0.87 and 0.92±0.23,respectively. The reduction of patients in the observation group was greater than that in the control group, and the data was statistically significant(t=11.270, 10.820, 8.88,P<0.05). The treatment effect of the observation group was better than that of the control group, and the data was statistically significant(z=-3.253, P<0.05). During the course of treatment, there was no statistically significant difference in the incidence of adverse events between the two groups(χ~2=0.345, 1.012, 0.000, P>0.05). Conclusion:Using lumbar fumigation combined with physical factors to treat patients with bone hyperplasia and low back pain can relieve pain and improve treatment effect, and has good safety.
Objective:To explore the clinical effect of lumbar stagnation combined with physical factors in the treatment of bone hyperplasia and low back pain. Methods:86 patients with osteoproliferative low back pain were selected. According to the random number method, the patients were divided into two groups, the control group and the observation group, with 43 patients in each group. Patients in the control group were treated with physical factors, while those in the observation group were given lumbar fumigation on the basis of the treatment methods in the control group. Comparisons of pain severity, serum secretory protein Dickkopf-1(DKK-1) and osteocalcin levels, therapeutic effects and adverse reactions were carried out. Results:After treatment, the pain score index(PRI), visual analog scale(VAS), and current pain status(PPI) scores of the control group were 21.11±3.86, 8.13±1.35 and 3.73±0.83. The score was reduced to 13.51±3.15, 4.51±0.97 and 1.57±0.48. The PRI, VAS and PPI scores of the observation group were reduced from 20.86±4.01, 8.21±1.47 and 3.86±0.79 to 7.06±2.04, 2.36±0.87 and 0.92±0.23,respectively. The reduction of patients in the observation group was greater than that in the control group, and the data was statistically significant(t=11.270, 10.820, 8.88,P<0.05). The treatment effect of the observation group was better than that of the control group, and the data was statistically significant(z=-3.253, P<0.05). During the course of treatment, there was no statistically significant difference in the incidence of adverse events between the two groups(χ~2=0.345, 1.012, 0.000, P>0.05). Conclusion:Using lumbar fumigation combined with physical factors to treat patients with bone hyperplasia and low back pain can relieve pain and improve treatment effect, and has good safety.
引文
[1] 郭永忠.舒筋壮骨方内服外敷联合物理疗法治疗膝关节骨质增生的疗效及对患者焦虑情绪的影响[J].陕西中医,2018,39(1):98-100.
[2] 黎丹东,李琳琳,张旭辉,等.膝骨关节炎非手术治疗的动物实验研究进展[J].医学综述,2018,24(10):2057-2063.
[3] 张天民,刘建民,王若林,等.针刀医学对骨质增生的新认识[J].中国医药导报,2017,14(15):156-158.
[4] 陆洪军,解云川,李长德,等.自拟抑骨质增生汤联合双氯芬酸钠治疗颈腰椎骨质增生的临床疗效及机理研究[J].中医药信息,2017,34(4):107-110.
[5] 朱艳,董杏薇.物理疗法治疗膝关节骨质增生的临床护理配合[J].实用手外科杂志,2018,32(2):257-258.
[6] 杨国强,张靳,廖伟,等.中药联合推拿、针灸对骨质增生的临床疗效[J].湖北中医药大学学报,2017,19(4):101-103.
[7] 曾宏,涂明道.穿龙骨刺胶囊联合骨肽注射液治疗骨质增生症的疗效观察[J].现代药物与临床,2017,32(7):1333-1336.
[8] 李文星,裴久国,徐胜珍,等.针刀整体松解术配合手法治疗膝骨性关节炎临床研究[J].中医学报,2017,32(8):1437-1440.
[9] 孙树椿.临床骨伤科学[M].北京:人民卫生出版社,2006:888-896.
[10] 国家中医药管理局.中医病证诊断疗效标准[S].南京:南京大学出版社,1994:48-49.
[11] 彭琳,张菊英.简化McGill疼痛问卷中文版在腰椎间盘突出所致坐骨神经痛患者中的适用性[J].中国康复医学杂志,2013,28(11):1035-1040.
[12] 张彦鸣,刘晓芳.综合护理在膝关节骨质增生患者中的应用评价[J].检验医学与临床,2016,13(11):1553-1554.
[13] 马志刚,李艳.腰椎骨质增生患者自身腰椎与髋骨骨密度测量结果分析[J].山东医药,2016,56(41):89-91.
[14] 张森,奚级梅,庞华,等.SPECT/CT 对脊柱转移性骨肿瘤与骨质退行性病变的诊断价值[J].医学临床研究,2015(7):1327-1330.
[15] 吴三梅,张卉,周敏,等.中药治疗联合针灸推拿缓解膝关节增生性骨关节病的效果研究[J].针灸临床杂志,2015,31(11):11-13.
[16] 熊屹,杨彦君,唐良华,等.苗药消刺通络膏治疗膝关节骨质增生的临床疗效观察[J].贵阳中医学院学报,2015,37(3):58-60.
[17] 刘庆立.穴位贴敷治疗贴治疗骨科椎骨关节疾病疗效观察[J].河南中医,2015,35(2):308-310.
[18] 姜明宇.分析小针刀疗法治疗跟骨骨质增生的效果及对住院时间、疼痛持续时间及不良反应的影响[J].中西医结合心血管病电子杂志,2016,4(32):85.
[19] 杨相丞.中西医结合治疗骨质增生的疗效分析[J].临床医药文献电子杂志,2016,3(28):5594-5595.
[20] 陈贵斌.“骨质增生”和“骨质退变”的辨证关系与临床意义见解[J].临床医药文献电子杂志,2017,4(37):7192.
[21] 杨磊.对骨质增生采用中草药剂外贴治疗的临床效果探讨[J].当代医学,2016,22(11):161-162.
[22] 刘志宏.补肾活血汤治疗骨质增生的效果观察[J].世界临床医学,2016,10(5):149.
[23] 葛维斌.中药配合物理疗法治疗膝关节骨质增生的疗效观察[J].临床医药文献电子杂志,2016,3(5):817-818.
[24] 徐立伟.补肾抗骨质增生丸配合熏洗治疗膝关节骨性关节炎临床疗效分析[J].中国实用医药,2016(1):161-162.
[2] 黎丹东,李琳琳,张旭辉,等.膝骨关节炎非手术治疗的动物实验研究进展[J].医学综述,2018,24(10):2057-2063.
[3] 张天民,刘建民,王若林,等.针刀医学对骨质增生的新认识[J].中国医药导报,2017,14(15):156-158.
[4] 陆洪军,解云川,李长德,等.自拟抑骨质增生汤联合双氯芬酸钠治疗颈腰椎骨质增生的临床疗效及机理研究[J].中医药信息,2017,34(4):107-110.
[5] 朱艳,董杏薇.物理疗法治疗膝关节骨质增生的临床护理配合[J].实用手外科杂志,2018,32(2):257-258.
[6] 杨国强,张靳,廖伟,等.中药联合推拿、针灸对骨质增生的临床疗效[J].湖北中医药大学学报,2017,19(4):101-103.
[7] 曾宏,涂明道.穿龙骨刺胶囊联合骨肽注射液治疗骨质增生症的疗效观察[J].现代药物与临床,2017,32(7):1333-1336.
[8] 李文星,裴久国,徐胜珍,等.针刀整体松解术配合手法治疗膝骨性关节炎临床研究[J].中医学报,2017,32(8):1437-1440.
[9] 孙树椿.临床骨伤科学[M].北京:人民卫生出版社,2006:888-896.
[10] 国家中医药管理局.中医病证诊断疗效标准[S].南京:南京大学出版社,1994:48-49.
[11] 彭琳,张菊英.简化McGill疼痛问卷中文版在腰椎间盘突出所致坐骨神经痛患者中的适用性[J].中国康复医学杂志,2013,28(11):1035-1040.
[12] 张彦鸣,刘晓芳.综合护理在膝关节骨质增生患者中的应用评价[J].检验医学与临床,2016,13(11):1553-1554.
[13] 马志刚,李艳.腰椎骨质增生患者自身腰椎与髋骨骨密度测量结果分析[J].山东医药,2016,56(41):89-91.
[14] 张森,奚级梅,庞华,等.SPECT/CT 对脊柱转移性骨肿瘤与骨质退行性病变的诊断价值[J].医学临床研究,2015(7):1327-1330.
[15] 吴三梅,张卉,周敏,等.中药治疗联合针灸推拿缓解膝关节增生性骨关节病的效果研究[J].针灸临床杂志,2015,31(11):11-13.
[16] 熊屹,杨彦君,唐良华,等.苗药消刺通络膏治疗膝关节骨质增生的临床疗效观察[J].贵阳中医学院学报,2015,37(3):58-60.
[17] 刘庆立.穴位贴敷治疗贴治疗骨科椎骨关节疾病疗效观察[J].河南中医,2015,35(2):308-310.
[18] 姜明宇.分析小针刀疗法治疗跟骨骨质增生的效果及对住院时间、疼痛持续时间及不良反应的影响[J].中西医结合心血管病电子杂志,2016,4(32):85.
[19] 杨相丞.中西医结合治疗骨质增生的疗效分析[J].临床医药文献电子杂志,2016,3(28):5594-5595.
[20] 陈贵斌.“骨质增生”和“骨质退变”的辨证关系与临床意义见解[J].临床医药文献电子杂志,2017,4(37):7192.
[21] 杨磊.对骨质增生采用中草药剂外贴治疗的临床效果探讨[J].当代医学,2016,22(11):161-162.
[22] 刘志宏.补肾活血汤治疗骨质增生的效果观察[J].世界临床医学,2016,10(5):149.
[23] 葛维斌.中药配合物理疗法治疗膝关节骨质增生的疗效观察[J].临床医药文献电子杂志,2016,3(5):817-818.
[24] 徐立伟.补肾抗骨质增生丸配合熏洗治疗膝关节骨性关节炎临床疗效分析[J].中国实用医药,2016(1):161-162.